Suppr超能文献

基于 Cockcroft-Gault 肌酐清除率、MDRD-4、CKD-EPI 和欧洲肾脏功能协会公式估算肾小球滤过率对急性冠脉综合征患者的预后价值。

Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromes.

机构信息

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

Institut für Laboratoriumsmedizin, Deutsches Herzzentrum München, Technische Universität, Munich, Germany.

出版信息

Clin Chim Acta. 2021 Dec;523:106-113. doi: 10.1016/j.cca.2021.09.007. Epub 2021 Sep 13.

Abstract

BACKGROUND

It remains unknown which equation used to assess the glomerular function is better for risk stratification in patients with acute coronary syndrome (ACS).

METHODS

This study included 3985 patients with ACS. Glomerular function was assessed using 4 equations: the Cockcroft-Gault creatinine clearance (C-G), Modification of Diet in Renal Disease-4 (MDRD-4), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and European Kidney Function Consortium (EKFC) equations. The primary outcome was one-year all-cause mortality.

RESULTS

For each 30 ml/min decrement, the adjusted hazard ratio [HR] with 95% confidence interval [CI] for one-year mortality was 1.67 [1.27-2.25] for C-G, 1.45 [1.16-1.81] for MDRD-4, 1.76 [1.35-2.30] for CKD-EPI and 1.94 [1.44-2.63] for EKFC equation. Area under the receiver operating characteristic curve (AUC) for one-year mortality was 0.748 [0.709-0.788] for C-G, 0.670 [0.621-0.718] for estimated glomerular filtration rate (eGFR) calculated by MDRD-4 equation, 0.725 [0.684-0.765] for eGFR calculated by CKD-EPI equation and 0.741 [0.703-0.779] for eGFR calculated by EKFC equation (P = 0.342 for C-G, vs. EKFC equation and P ≤ 0.009 for all other AUC comparisons).

CONCLUSIONS

In patients with ACS, C-G and EKFC equations showed a similar discriminatory power regarding prediction of one-year mortality. Both equations were better than MDRD-4 and CKD-EPI equations for risk discrimination for mortality.

CLINICAL TRIAL REGISTRATION

NCT01944800.

摘要

背景

目前尚不清楚用于评估肾小球功能的哪种方程更适合急性冠状动脉综合征(ACS)患者的风险分层。

方法

本研究纳入了 3985 例 ACS 患者。使用 4 种方程评估肾小球功能: Cockcroft-Gault 肌酐清除率(C-G)、肾脏病饮食改良试验-4(MDRD-4)、慢性肾脏病流行病学合作研究(CKD-EPI)和欧洲肾脏功能协作组(EKFC)方程。主要终点为 1 年全因死亡率。

结果

每降低 30ml/min,C-G 方程校正后的 1 年死亡率的危险比[HR]及 95%置信区间[CI]为 1.67[1.27-2.25],MDRD-4 方程为 1.45[1.16-1.81],CKD-EPI 方程为 1.76[1.35-2.30],EKFC 方程为 1.94[1.44-2.63]。1 年死亡率的受试者工作特征曲线(ROC)下面积(AUC)为 C-G 为 0.748[0.709-0.788],MDRD-4 方程估算的肾小球滤过率(eGFR)为 0.670[0.621-0.718],CKD-EPI 方程为 0.725[0.684-0.765],EKFC 方程为 0.741[0.703-0.779](C-G 与 EKFC 方程比较 P=0.342,与其他所有 AUC 比较 P≤0.009)。

结论

在 ACS 患者中,C-G 和 EKFC 方程在预测 1 年死亡率方面具有相似的区分能力。这两种方程在预测死亡率方面的风险判别能力均优于 MDRD-4 和 CKD-EPI 方程。

临床试验注册

NCT01944800。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验